show episodes
 
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
  continue reading
 
Artwork

1
The Top Line

Fierce Life Sciences

Unsubscribe
Unsubscribe
Weekly
 
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
  continue reading
 
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
  continue reading
 
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
  continue reading
 
Artwork

1
Life Science Today

Noah Goodson, PhD

Unsubscribe
Unsubscribe
Monthly
 
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
  continue reading
 
Artwork

1
CFR On the Record

Council on Foreign Relations

Unsubscribe
Unsubscribe
Monthly
 
A chance to go inside Council on Foreign Relations events. Listen to world leaders and foreign policy experts discuss and debate the most pressing issues in international affairs.
  continue reading
 
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
  continue reading
 
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
  continue reading
 
Join Hercules Capital in conversations with today’s top CEOs, CFOs, and investors in venture and private equity-backed companies. Learn about their strategies for financing rapid growth and scaling their businesses, as well as their unique interests and life stories that have shaped their paths to success.
  continue reading
 
First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO with episodes launching weekly on Tuesday's. 🎧 Stay in the Loop! For the latest news and updates, visit our website: https://vial.com Follow us on social media for real-time insights: Twitter: https://twitter.com/VialTrials LinkedIn: https://www.linkedin.com/company/vialtrials
  continue reading
 
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
  continue reading
 
Loading …
show series
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.J&J plans to change how it pays out discounts to 340B-eligible drugs, causing concerns for hospitals and the government. A report by the HHS' Office of Inspector General found that 1 in 4 for-profit nursing homes are not co…
  continue reading
 
Proactive's Billy Farrington takes Stephen Gunnion through recent movements in the cryptocurrency market, particularly focusing on Bitcoin. Farrington highlighted that Bitcoin experienced a volatile week, with prices dropping by 5% against the dollar, driven by ongoing recession fears in the U.S. and significant outflows from Bitcoin exchange-trade…
  continue reading
 
The FTSE enjoyed a bright start on Friday, gaining 31 points to reach 8,411. This took the index ever closer to its record high seen in May of 8,447 in intraday trading and an 8,445 close.The move up came despite little company news and another tough night for Nvidia.Traditional safe stocks such as utilities and property groups were going well in e…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Clinical trials often fail to meet their enrollment goals and schedules, leading to significant financial losses. A new playbook offers solutions to address common challenges in clinical trial recruitment, including strateg…
  continue reading
 
archTIS Ltd (ASX:AR9) CEO Daniel Lai joins Proactive’s Tylah Tully to discuss its 2024 financial year, which was highly successful with the company reporting a 54% increase in revenue and a positive operating cash flow of A$1.6 million.archTIS is known for its secure collaboration solutions for sensitive information and achieved record-breaking cas…
  continue reading
 
STAT biotech reporter Jonathan Wosen joins us to discuss gene therapy pioneer Jim Wilson's exit from his decades-long tenure at the University of Pennsylvania. We also discuss the latest news in the life sciences, including the surprising collapse of a gene editing company, Eli Lilly's pitch to consumers, and more.…
  continue reading
 
Reconnaissance Energy Africa CEO Brian Reinsborough joined Steve Darling from Proactive to provide an update on the company’s financial performance for the recent quarter, highlighting several key developments.Reinsborough discussed the progress on the Naingopo exploration well, which has reached a depth of over 2,400 meters (7,875 feet). This well…
  continue reading
 
BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to discuss the company’s impressive financial and operational results for the second quarter of 2024. For the first time, BioHarvest Sciences reported revenue surpassing the $6 million mark, reaching $6.03 million. This represents a 119% increase compared to the $2.8 million rep…
  continue reading
 
Firefly Neuroscience Executive Chair Dave Johnson joined Steve Darling from to announce the company's strategic partnership with the Neurology Consultants of Dallas (NCD). This collaboration aims to enhance early detection efforts and improve disease management for patients experiencing cognitive decline.Johnson explained that NCD will integrate Fi…
  continue reading
 
In this week's episode of "The Top Line," we look at factors driving the continuing decline of flu vaccination rates in the U.S. and beyond. Fierce Pharma’s Zoey Becker chats with Gregg Sylvester, M.D., Chief Health Officer at CSL Seqirus, to get insight on what we might expect to see from this upcoming flu season. He also explains efforts to incre…
  continue reading
 
The FTSE 100 inched higher in early trades as investors mulled the share price slide in Nvidia overnight despite more impressive numbers.London’s blue-chip index was up eight at 8,352 though Nvidia shares fell almost 7% in overnight trading. This was as sales more than doubled over the second quarter to US$30 billion with guidance of US32.5 billion…
  continue reading
 
Surefire Resources NL (ASX:SNR) managing director Paul Burton joins Proactive’s Tylah Tully to discuss progress at the Victory Bore Vanadium Project. The company has made a series of strategic agreements - a joint cooperation agreement (JCA) with Mid West Ports Authority and a heads of agreement with DRA Global Ltd for a total engineering services …
  continue reading
 
Elixir Energy (ASX:EXR, OTC: ELXPF) managing director Neil Young joins Proactive’s Tylah Tully to discuss developments at the Daydream-2 well within Project Grandis in Queensland's Taroom Trough. The well is now in the clean-up phase, with gas and completion fluid flowing back to the surface without assistance after the successful removal of all te…
  continue reading
 
Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to discuss the company's significant global expansion and the strategic initiatives driving its success. Stratmann provided an update on ongoing projects in key regions such as the Middle East and Latin America, where there is a growing demand for the company's advan…
  continue reading
 
Theralase Technologies CEO Roger DuMoulin-White joined Steve Darling from Proactive to announce a significant advancement in cancer treatment. The company's lead drug formulation, Rutherrin, has demonstrated a remarkable ability to enhance the efficacy of Cisplatin, a commonly prescribed chemotherapy drug, in treating chemotherapy-resistant Non-Sma…
  continue reading
 
Torr Metals CEO Malcom Dorsey joined Steve Darling from Proactive to reveal final assay results from a total of 33 rock grab samples collected during the company's 2024 reconnaissance programs. These results have identified additional high-grade rock grab assays within the Kirby, Rea, and Clapperton exploration target zones. Notably, a new copper-g…
  continue reading
 
OS Therapies CEO Paul Romness joined Steve Darling from Proactive to share news the company has been accepted into Johnson & Johnson Innovation – JLABS, a prestigious platform that supports innovation in the life sciences sector. Through this membership, OS Therapies aims to advance its tunable Antibody Drug Conjugate (ADC) linker-based platform in…
  continue reading
 
In this episode, Ayesha spoke with Steffen-Sebastian Bolz, MD, PhD, a scientist, physician and entrepreneur. He is a Co-Founder of Aphaia Pharma AG and Founder and Chief Scientific and Medical Officer at Qanatpharma AG. Dr. Bolz holds a full professorship at the University of Toronto, is a Principal Investigator at the Ted Rogers Centre for Heart R…
  continue reading
 
Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently joined Steve Darling from Proactive to discuss the company's collaboration with Bilthoven Biologicals (BBio) to advance TNX-801, Tonix’s promising vaccine candidate for mpox. TNX-801 is a live, replicating, attenuated virus vaccine based on horsepox, currently in preclinical development to p…
  continue reading
 
Graft Polymer (UK) PLC CEO Anthony Tennyson takes Proactive's Stephen Gunnion through the progress the company has made in its commercial collaboration with Awakn Life Sciences.Tennyson explained the collaboration is aimed at developing new therapeutics for trauma-related mental health disorders, including post-traumatic stress disorder (PTSD).He n…
  continue reading
 
HeLIX Exploration PLC (AIM:HEX) chairman David Minchin talked with Proactive's Stephen Gunnion about the successful completion of drilling at the Clink #1 well within the Ingomar Dome project in Montana.Minchin noted the completion of drilling ahead of schedule and under budget, with helium shows detected across all target horizons. In an unexpecte…
  continue reading
 
London's FTSE 100 eased higher ahead of a big day on the US tech front with Nvidia and CrowdStrike to report later.London’s blue-chip index was up five points at 8,349 in early trades.GSK was a riser as the Delaware Supreme Court said it would review a previous adverse ruling in its Zantac litigation battle. The UK pharma company noted that such in…
  continue reading
 
Riversgold Ltd (ASX:RGL) chairman David Lenigas discusses the latest assay results from the Northern Zone Intrusive Hosted Gold Project, located 25 kilometres east-south-east of the Kalgoorlie Super Pit in Western Australia.Lenigas expressed enthusiasm about the recent drilling results, which exceeded the company’s expectations. He highlighted the …
  continue reading
 
Far East Gold Ltd (ASX:FEG) CEO Shane Menere joins Proactive’s Tylah Tully to discuss a successful $4 million capital raise to advance exploration at its Trenggalek, Idenburg and Woyla gold and copper projects in Indonesia.The capital was accumulated through a combination of an institutional placement, which raised $2.3 million, and a share purchas…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. A new healthcare AI accelerator program has been launched by Johns Hopkins, CareFirst, and Techstars, offering funding and guidance to startups working on AI tools. Medicare could face increased spending of $34 billion to …
  continue reading
 
Element 25 Ltd (ASX:E25, OTCQX:ELMTF) managing director Justin Brown joins Proactive’s Tylah Tully to discuss the completion of resource infill drilling at its 100%-owned Butcherbird Manganese Project in the Pilbara region of Western Australia.The campaign has successfully confirmed the continuity of mineralisation, boding well for future explorati…
  continue reading
 
Lumos Diagnostics Ltd (ASX:LDX, OTC:LDXHF) chief technology officer Sacha Dopheide joins Proactive’s Tylah Tully to discuss an extended agreement with Burnet Diagnostics Initiative (BDI) to further develop and manufacture a liver function test based on Alanine Transaminase (ALT) levels.The BDI agreement includes the production of ALT lateral flow t…
  continue reading
 
Bit Digital CEO Sam Tabor joined Steve Darling from Proactive to discuss the company's impressive unaudited financial results for the second quarter of 2024. Bit Digital experienced a significant revenue increase, achieving $29 million in total revenue for Q2, marking a 220% growth compared to the same period in 2023. This surge in revenue was larg…
  continue reading
 
SolarBank Corporation CEO Richard Lu joined Steve Darling from Proactive to share news about the company's latest venture—a 6.41 MW DC ground-mount solar power project in East Bloomfield, New York. Known as the East Bloomfield project, this initiative represents a significant step forward in SolarBank's mission to expand renewable energy infrastruc…
  continue reading
 
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF)CEO Lorna Blaisse discusses the company’s latest strategic move to diversify its portfolio and generate near-term cash flow with Proactive's Stephen Gunnion.Blaisse elaborated on the proposed acquisition of Blue Star Helium's Galactica-Pegasus asset in Colorado, emphasising its potential to position Heliu…
  continue reading
 
Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to announce significant new enhancements to the company's Aritize3D platform, powered by generative AI. Nextech3D.ai, a pioneer in 3D technology for e-commerce, continues to push the boundaries of innovation with these updates, aimed at enriching product experiences and simplifyin…
  continue reading
 
London's FTSE 100 opened 39 points higher at 8,366 as miners, oil companies and Bunzl lifted the index after the bank holiday. Oil prices surged on a shutdown in Libya lifting BP and Shell while BHP’s results overnight boosted the miners. Bunzl shares meanwhile jumped to a new all-time high after the distributor hiked its interim dividend 10%, laun…
  continue reading
 
Torque Metals Ltd (ASX:TOR) managing director Cristian Moreno joins Proactive’s Tylah Tully to discuss initial diamond drill results from the Paris Gold Project in the Western Australian Goldfields, which yielded a standout intersection of 22.15 metres at 12.14 g/t gold from 188.27 metres.The results from the recently completed 1,105-metre diamond …
  continue reading
 
West Wits Mining Ltd (ASX:WWI) chairman Michael Quinert joins Proactive’s Tylah Tully to discuss a successful $1.5 million capital raise to advance the flagship Qala Shallows operations, within the Witwatersrand Basin Gold Project in South Africa.As well as supporting the company’s transition to gold producer status, the funds will also cover consu…
  continue reading
 
Nexus Minerals Ltd (ASX:NXM) managing director Andy Tudor joins Proactive’s Tylah Tully to discuss promising early regional exploration results from the Wallbrook Gold Project in the north-eastern Goldfields of Western Australia.The company completed a regional aircore drilling program, comprising 239 holes for 9,467 metres, which targeted four sha…
  continue reading
 
Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) CEO Jason Carroll joins Proactive’s Tylah Tully to discuss the completion of dosing all participants in its Phase 1b IV-infused psilocin Healthy Human Volunteer Study conducted at CMAX Clinical Research in Adelaide.This trial involved the administration of TRP-8803, a proprietary IV-infused psilocin …
  continue reading
 
Fathom Nickel CEO Ian Fraser joined Steve Darling from Proactive to discuss the final results of the company's June soil and rock geochemistry program at the Gochager Lake Property. These results have provided significant insights, clearly demonstrating that the geochemical footprint of the Gochager Lake deposit has been extended by up to four kilo…
  continue reading
 
Blockmate Ventures Chairman Domenic Carosa joined Steve Darling from Proactive to discuss the company's latest strategic development. Blockmate Ventures, through its investee Hivello Holdings, has entered into a significant partnership with Mysterium Network, a decentralized Virtual Private Network (VPN) platform. This collaboration is designed to …
  continue reading
 
60 Degrees Pharmaceuticals CEO Geoff Dow joined Steve Darling from Proactive to share the company’s financial results for the second quarter of 2024 with Proactive, highlighting significant progress in both revenue growth and clinical development. Focused on developing new medicines for infectious diseases, the company saw its Q2 2024 net product r…
  continue reading
 
North Bay Resources CEO Jarad Lazerson joined Steve Darling from Proactive to share news of multiple high-grade gold assays from the company's Fran Gold Project. The samples were taken from the primary area of gold mineralization within the Bullion Alley Zone, particularly around Trenches B and C.Lazerson reported that these assays have returned re…
  continue reading
 
Gold Basin Resources CEO Colin Smith joined Steve Darling from Proactive to share the latest drill results from the recently completed resource expansion and delineation drill program at the company's Gold Basin oxide gold project in Arizona. This phase of drilling specifically targeted step-out collar locations along the previously undrilled north…
  continue reading
 
Arturo Prestamo, Executive Chairman and CEO of Santacruz Silver Mining joined Steve Darling from Proactive to announce the latest Mineral Resource and Reserve estimates for the company’s three producing assets in Bolivia: the Bolivar mine, the Porco mine, and the Caballo Blanco Group of mines. These estimates mark a significant milestone for Santac…
  continue reading
 
Biotherapeutics are transforming healthcare for over 350 million patients globally, tackling everything from cancer and diabetes to rare diseases. Human embryonic kidney (HEK) 293 cells play a key role in the manufacturing of many of these life-changing products. However, they are not without their challenges. In this episode of The Top Line, spons…
  continue reading
 
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward Health is closing two Ohio hospitals and a Pennsylvania facility due to financial reasons, drawing criticism from healthcare workers and unions. McLaren Health Care in Michigan is facing disruptions from a ransomwa…
  continue reading
 
Alligator Energy Ltd (ASX:AGE, OTC:ALGEF) CEO Greg Hall joins Proactive’s Tylah Tully to talk about a drilling program at the Nabarlek North Uranium Project in the Northern Territory of Australia, amid an upsurge in the uranium market.The project targets unconformity-style uranium deposits in the Lower Cahill Formation, similar to those at Ranger, …
  continue reading
 
Galileo Mining Ltd (ASX:GAL, OTC:GLMGF) managing director Brad Underwood joins Proactive’s Tylah Tully to discuss a drilling campaign at the Callisto North prospect, part of its 100%-owned Norseman Project in Western Australia.The RC drilling is targeting platinum group elements (PGE) and nickel-copper along the same trend that hosts the Callisto d…
  continue reading
 
For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of agencies. This stipulation, called the Chevron deference, gave agencies room to advance their regulatory priorities. The Supreme Court overturned the doctrine in June, bringing significant implications …
  continue reading
 
Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF) president and CEO Segun Lawson speaks to Proactive's Stephen Gunnion about the company's robust performance in Q2 2024, particularly at its Segilola Gold Mine in Nigeria.Lawson highlighted that the company achieved record gold production and net profits during the quarter, driven by recent plant…
  continue reading
 
London's FTSE 100 ticked up on Friday morning in a quiet day for company news. Leading headlines was confirmation from Ofgem that energy prices would be hiked by 10% this October following a rise in wholesale prices, affecting 28 million households.Consumer confidence figures for August showed sentiment remained unchanged month-on-month after hitti…
  continue reading
 
KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF) executive chairman Harry Anagnostaras-Adams tells Proactive's Stephen Gunnion about the company’s significant progress in Ethiopia, following a period of economic and political instability in the country.Anagnostaras-Adams highlighted Ethiopia’s resurgence as a key player in Africa, drawing parallels b…
  continue reading
 
Loading …

Quick Reference Guide